欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/V/0119/001
药品名称Biocan Novel DHPPi/L4R, lyophilisate and solvent for suspension for injection for dogs
活性成分
    • canine adenovirus 5.3 TCID50
    • canine distemper virus 5.1 TCID50
    • canine parainfluenza virus 5.1 TCID50
    • canine parvovirus 6.6 TCID50
    • leptospira interrogans serogroup canicola 51.0 ALR
    • leptospira interrogans serogroup icterohaemorragiae 51.0 ALR
    • Rabies virus, inactivated 2.0 IU
剂型Lyophilisate and Solvent
上市许可持有人Bioveta, a.s. Komenskeho 212 683 23 Ivanovice na Hane Czech Republic tel.: + 420 517 318 502 fax: + 420 517 318 653 linhart.jakub@bioveta.cz comm@bioveta.cz
参考成员国 - 产品名称Czechia (CZ)
Biocan Novel DHPPi/L4R, lyofilizát a rozpouštědlo pro injekční suspenzi pro psy
互认成员国 - 产品名称
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
      Biocan Novel DHPPi/L4R
    • Hungary (HU)
      Biocan Novel DHPPi/L4R vakcina A.U.V.
    • Bulgaria (BG)
    • Cyprus (CY)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2014/06/18
最近更新日期2024/05/15
药物ATC编码
    • QI07AJ06 live canine distemper virus + live canine adenovirus + live parainfluenza virus + live canine parvovirus + inactivated rabies + inactivated leptospira
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase